All rights reserved. He succeeds Emma Walmsley who was last week appointed GSK CEO Designate succeeding Sir Andrew Witty as GSK CEO. Brian has 5 jobs listed on their profile. 6,257 views. He will join GSK’s Corporate Executive Team effective immediately and will continue as a member of the Board of the Consumer Healthcare Joint Venture with Novartis.
0 faves In all of our interactions with HCPs we aim to be transparent about our work, operate with integrity, and always put the interests of patients first.Site intended for a US audience only.Explore the latest news, different ways to stay in touch and available useful resourcesBrian is currently Head of Europe & Americas at GSK Consumer Healthcare. When you look at full year growth for the business, we grew 2%. In his new role, Brian will report to Andrew Witty until Emma becomes CEO. "Now the deal has closed, our focus will be on completing the integration of these two businesses and leveraging their combined strength," McNamara said. The Consumer Healthcare business develops and markets products in Wellness, Oral health, Nutrition and Skin health with a portfolio of some of the world’s most trusted and best-selling brands which include Sensodyne, Voltaren and Panadol. Led by CEO Brian McNamara, the combined business will operate globally as GSK Consumer Healthcare. Brian McNamara is on the board of Consumer Healthcare Products Association, The Consumer Goods Forum and Association of the European Self-Medication Industry and Chief Executive Officer-Consumer Healthcare at GlaxoSmithKline Plc. Choose your path.Keep up to date with our news and recent announcements© 2001-2018 GSK group of companies. He is a member of the Corporate Executive Team.Brian joined Novartis in 2004 as Senior Vice President of the North America OTC business. Choose your path.Keep up to date with our news and recent announcementsBrian McNamara was appointed as CEO, GSK Consumer Healthcare in September 2016. He will be based in the UK.We make a wide range of prescription medicines, vaccines and consumer healthcare products.Science can improve health and well-being in so many ways, from the development of everyday convenience healthcare products through to life-saving medicines and vaccinesWe are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.Responsible business is how we do business. GSK today announced that Brian McNamara, is appointed Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division effective immediately. LONDON, 29-Sep-2016 — / EuropaWire / — GSK today announced that Brian McNamara, is appointed Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division effective immediately. Brian McNamara, CEO, GSK Consumer Healthcare Done. Brian McNamara biography Brian McNamara serves as Chief Executive Officer - GSK Consumer Healthcare of the Company. Thanks, Emma, and thanks, James. He joined GSK from Novartis following completion of GSK’s three-part transaction with Novartis and has been a member of GSK’s Consumer Healthcare Executive Team since 2015.GSK today announced that Brian McNamara, is appointed Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division effective immediately.We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.Meet some of our employees in research and development, manufacturing and supply, sales and marketing and various other roles.He succeeds Emma Walmsley who was last week appointed GSK CEO Designate succeeding Sir Andrew Witty as GSK CEO. The Consumer Healthcare business develops and markets products in Wellness, Oral health, Nutrition and Skin health with a portfolio of some of the world’s most trusted and best-selling brands which include Sensodyne, Voltaren and Panadol. Brian McNamara, GlaxoSmithKline plc - CEO of GSK Consumer Healthcare [4] Yes.
He succeeds Emma Walmsley who was last week appointed GSK CEO Designate succeeding Sir Andrew Witty as GSK CEO. He is also a Board Member of the Consumer Goods Forum (CGF).
He was previously a Board Member and Chairman of the Economic Affairs Committee, Association for Europe Self-Medication Association (AESGP) and Board Member and Vice Chairman, Consumer Health Products Association (CHPA).Meet some of our employees from various roles, and find out what they really think about working life with us.Responsible business is how we do business.
Previously, as head of Novartis’s OTC division, Brian was a driving force behind the formation of the joint venture and the development of the 3 Year JV strategic and operational plan.We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.Brian is a Board Member of the World Self-Medication Industry Association (WSMI), having served as Chairman from February 2017 to March 2019.